Prof David Celermajer: “Science is our only hope to save the planet”

Meet the team
Watch Professor David Celermajer's inspiring Keynote Address from Illuminate 2016.

Professor David Celermajer is the Clinical Director of HRI, a professor and heart specialist at RPA and he's a doctor three times over. As well as his medical qualifications, he has a Masters from Oxford, a PhD in children's heart disease from London University and a PhD in Science from this very university. He was also world debating champion and public speaking champion in the 1980s, where the topic with which he won was ‘Why We Shouldn’t Play Leap Frog with Unicorns'.


Related news

Silk mends broken hearts

The world’s most luxurious fabric could soon be used to weave blood vessels that offer life to heart bypass patients, a breakthrough HRI study has found. Scientists at HRI in Sydney built and tested silk blood vessels and discovered they’re more effective and better tolerated than synthetic materials currently used in Australian hospitals. 

Read more

Crystal ball molecule predicts diabetes before it strikes

HRI researchers have developed a simple test to predict diabetes more than a decade before it strikes, a breakthrough that could help ease the impending diabetes epidemic. The team has uncovered an important molecule found in liver fat that can identify who is most at risk of developing diabetes and other cardio-metabolic disorders like liver disease.  

Read more

New drug hope to target silent killer

An exciting new treatment for very high blood pressure is on the horizon after a world-first discovery by Heart Research Institute scientists, who have uncovered a brain chemical instrumental in triggering hypertension, the so-called silent killer responsible for the deaths of thousands of Australians each year.

The researchers are optimistic the results, published this week in the American Journal of Physiology-Heart and Circulatory Physiology, will ultimately lead to a powerful new treatment that blocks a neurotransmitter and frees patients from the dangers of hypertension. 

Read more